Latest filing published 22 Dec 2024 for InMed Pharmaceuticals Inc..
Insider track record
No signal scores available.
Michael Henry Woudenberg: trading record in brief
This profile gathers the share dealings of Michael Henry Woudenberg in InMed Pharmaceuticals Inc. We count 2 filings; the first trade dates from 7 September 2022 and the latest from 14 November 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 22 December 2024 came the latest disclosure, a transaction in InMed Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Henry Woudenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21 sharesCommon SharesTSXSEDI:4423056
- 509 sharesCommon SharesTSXSEDI:4017826
2 of 2 declarations